BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2942724)

  • 1. Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma.
    Young MR; Hoover CS
    J Natl Cancer Inst; 1986 Aug; 77(2):425-9. PubMed ID: 2942724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
    Young MR; Young ME; Wepsic HT
    Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo.
    Young MR; Knies S
    J Natl Cancer Inst; 1984 Apr; 72(4):919-22. PubMed ID: 6584667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fish oil and corn oil diets on prostaglandin-dependent and myelopoiesis-associated immune suppressor mechanisms of mice bearing metastatic Lewis lung carcinoma tumors.
    Young MR; Young ME
    Cancer Res; 1989 Apr; 49(8):1931-6. PubMed ID: 2522813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
    Young MR; Newby M
    J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma.
    Young MR; Wheeler E; Newby M
    J Natl Cancer Inst; 1986 Apr; 76(4):745-50. PubMed ID: 3457207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of tumor-induced myelopoiesis and the associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma by prostaglandin E2.
    Young MR; Young ME; Kim K
    Cancer Res; 1988 Dec; 48(23):6826-31. PubMed ID: 2972359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement in immunity of tumor bearing mice by immunization against prostaglandin E2.
    Young MR; Henderson S
    Immunol Commun; 1982; 11(5):345-56. PubMed ID: 6961100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.
    Young MR; Duffie GP; Lozano Y; Young ME; Wright MA
    Cancer Res; 1990 May; 50(10):2973-8. PubMed ID: 2159367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages.
    Young MR; Newby M
    Cancer Res; 1986 Jan; 46(1):160-4. PubMed ID: 3455665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors.
    Young MR; Newby M; Wepsic HT
    Cancer Res; 1987 Jan; 47(1):100-5. PubMed ID: 2947676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosubversive role of PGE2 in tumor bearing mice.
    Ippoliti F; Sezzi ML; Bellelli L; Naso G; Pontieri GM
    Boll Ist Sieroter Milan; 1985; 64(1):25-34. PubMed ID: 3859302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of immune function and tumor growth inhibition by antibodies against prostaglandin E2.
    Young MR; Dizer M
    Immunol Commun; 1983; 12(1):11-23. PubMed ID: 6573300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of teichoic acid from S. aureus on metabolic activity of macrophages and cytotoxic activity of splenocytes of mice bearing Lewis lung carcinoma.
    Potebnya GP; Skivka LM; Pozur VV; Rudik MP; Senchilo NV; Fedorchuk OG; Khranovska NM
    Exp Oncol; 2008 Sep; 30(3):220-3. PubMed ID: 18806745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the growth of Lewis lung carcinoma by indomethacin in conventional, nude, and beige mice.
    Maca RD
    J Biol Response Mod; 1988 Dec; 7(6):568-80. PubMed ID: 3216222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 production by EL 4 leukemia cells from C57BL/6 mice: mechanism for tumor dissemination.
    Mahan M; Meunier J; Newby M; Young MR
    J Natl Cancer Inst; 1985 Jan; 74(1):191-5. PubMed ID: 3855478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of cloned high- and low-metastatic murine Lewis lung tumor cells to lysis by cytotoxic autoreactive cells.
    Olsson L; Kiger N; Kronstrom H
    Cancer Res; 1981 Nov; 41(11 Pt 1):4706-9. PubMed ID: 6975655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of recombinant murine interferon-gamma on the hematopoietic and immunological parameters of mice bearing metastatic Lewis lung carcinoma tumors.
    Young MR; Young ME; Wepsic HT
    Exp Hematol; 1988 May; 16(4):295-301. PubMed ID: 2966070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumoricidal activity of alveolar and peritoneal macrophages of C57BL/6 mice bearing metastatic or nonmetastatic variants of Lewis lung carcinoma.
    Duffie GP; Young MR
    J Leukoc Biol; 1991 Jan; 49(1):8-14. PubMed ID: 1984486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between morphology, dissemination, migration, and prostaglandin E2 secretion by cloned variants of Lewis lung carcinoma.
    Young MR; Newby M; Meunier J
    Cancer Res; 1985 Aug; 45(8):3918-23. PubMed ID: 3860290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.